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Abstract
Background: There is only scarce information on the
incidence and costs of stroke in Belgium. Knowledge of
these figures permits targeted allocation of resources and
aids cost efficacy estimates.
Methods: We analysed a nationwide administrative
database used for reimbursement of hospitals in Belgium.
This database allows analysis of the rate of all hospital
admissions for TIA, acute ischemic stroke, intracranial
hemorrhage and carotid surgery or angioplasty. We com-
pared the costs of hospitalization for stroke and related
disorders with the costs of hospitalization for coronary
artery disease. 
Results: There were 32970 admissions for stroke re-
lated disorders in 2007 at a cost of 191.6 million EUROS.
There was a decline of 4.7% of the rate of hospitalization
for stroke and associated disorders over the period 2002-
2007. Despite this decline the total costs did not diminish
substantially. In 2007 stroke and related disorders
 accounted for 2.0% of all Belgian hospitalizations,
whereas coronary artery disease hospitalization
 accounted for 4.4%. The length of stay was longer for
stroke and associated disorders. The average cost of
 hospitalizations in 2007 for stroke related disorders was
6188 EURO and the average cost of coronary artery
 related disorders was 5026 EURO. 
Conclusion: The cost of hospitalization for stroke and
related disorders is high. Although coronary artery  disease
is more frequent and has a larger impact on the health care
expenditures, the average cost per hospitali zation is higher
for stroke and related diseases. This is mainly due to the
longer hospitalization duration for stroke.
Key words: health economics; carotid endarterectomy;
stroke; cerebrovascular disorders; Transient ischemic
 attack.
Introduction
stroke is the most important cause of disability in
adults. The health care costs incurred by govern-
ments, insurance companies or patients (i.e., the
 direct medical costs) in the first year after stroke
have been estimated to vary between 5435 euRO
and 13409 euRO in european countries (1-5). Data
on the costs of stroke have not been analyzed sys-
tematically in Belgium. One Belgian study estimated
a cost of 5990 euRO for hospitalization and
11445 euRO for follow up costs up to two years
after acute ischemic stroke (6). These estimates were
based on data from a single hospital from the  mid-
nineties. information on the current costs of stroke
is of interest because an accurate cost estimate can
be used for better allocation of resources and can be
used for cost-effectiveness analyses. 
There are only a limited number of studies in
 Belgium on the incidence and prevalence of stroke.
One study, based on data from 178 general practi-
tioner (GP) sentinel practices, estimated a yearly
 incidence of stroke of 185 per 100000 inhabitants in
the period 1998-1999 (7). The inTeGO network, a
second GP network limited to the Flanders region in
Belgium estimates an incidence of 2.18 per thousand
yearly patient contacts in 2008, but translation to an
exact population based incidence rate is not straight-
forward (8, 9). in the Belgian health survey of 2008,
the prevalence of stroke among respondents aged 65
or more was three percent (10). These studies have
limitations however as the registration by GPs might
be  incomplete and self-reported stroke diagnoses are
not always accurate. an accurate way of real time
monitoring of stroke incidence would be valuable. 
The all Patient Refined Diagnostic Related
Groups (aPR-DRG) is a system to classify patients
admitted to hospital into groups expected to have
similar resource use. in order to assign patients to
the DRG, information on icD-9 diagnoses, the use
of procedures, age, sex and the presence of compli-
cations and comorbidities is provided to a software
tool to create categories of patients. note that this
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system is not intended as a diagnostic system, but as
a tool for reimbursement of homogenous groups of
patients with equivalent use of hospital resources.
as there is a lack of formal cost of stroke studies
in Belgium, we used data from an administrative
database based on the aPR-DRG system of hospi-
talizations to study the cost of stroke and related
 disorders in Belgium. we also probed whether this
database could be used to monitor the incidence of
hospitalized stroke in Belgium. 
Methods
DaTa sOuRces
we used data from the period 2002-2007 of the
“national Database medical Diagnosis/care &
cost” (11). This registry collects the medical diag-
noses anonymously from all patients that are admit-
ted overnight to all acute Belgian hospitals and the
costs charged to the healthcare insurances for each
admission. Briefly, hospitals provide icD9 diag-
noses and procedures for each hospital admission
and 3m grouper software generates the associated
medical diagnostic categories (mDc) and all Patient
Refined Diagnosis Related Groups (aPR-DRG, ver-
sion 15). The database links the mDc and DRG to
the costs charged for each admission to the health
insurance companies. information on age, sex and
length of stay is also collected. The icD-9 codes are
validated by audits of individual files by the ministry
of health. The costs are controlled by the insurance
companies and inami/RiZiV.
DeFiniTiOn OF sTROKe anD RelaTeD cOnDiTiOns
Online Table 1 shows the aPR-DRG which were
considered to be related to cerebrovascular disorders
in this study. There are some limitations to these
data. non-traumatic subdural hematomas are in-
cluded in the aPR-DRG 44, although this is strictly
not considered a stroke phenotype. Regarding aPR-
DRG 24, there is no information on the rate of
carotid intervention for symptomatic versus asymp-
tomatic carotid stenosis. Finally, intracerebral
hematomas for which a craniotomy is performed are
not coded as aPR-DRG 44 as these are included into
the broad aPR-DRG category 21 (craniotomy ex-
cept for trauma). For these analyses we will use the
term stroke related conditions as admissions with
aPR-DRG 24 & 44-47. The aPR-DRG 45 and 46
will be referred to as single category of ischemic
stroke. in patients with aPR-DRG 46 a definite di-
agnosis of ischemia versus intracerebral hemorrhage
is impossible. Yet, as the proportion of ischemic
stroke versus intracerebral hemorrhage is much
larger we elect to classify these as ischemic stroke.
aPR-DRG 44 will be considered ich and aPR-
DRG 47 as Tia. aPR-DRG 24 were considered as
carotid endarterectomies (cea).
DeFiniTiOn OF cOROnaRY aRTeRY Disease
Online Table 2 shows the aPR/DRG which were
related to coronary artery disease. we tried not to be
limitative for the definition of coronary artery
 disease. 
ValiDaTiOn OF aPR-DRG DaTa
First validation cohort
To validate the stroke and related conditions
 coding data we compared the discharge diagnosis of
patients enrolled in the stroke Registry of the stroke
APR DRG 24 extracranial vascular procedures
44 intracranial hemorrhage
45 cVa with brain infarction
46 nonspecific cVa and precerebral occlusion
without brain infarction
47 Transient ischemia
Online Table 1
stroke and related conditions
APR DRG 165 coronary bypass without malfunctioning
coronary bypass with cardiac catheterisa-
tion
166 coronary bypass without malfunctioning
coronary bypass without catheterization
170 Permanent cardiac Pacemaker implant with
acute myocardial infarction, shock or heart
failure
174 Percutaneous coronary intervention with
myocardial infarction
175 Percutaneous coronary intervention with -
out myocardial infarction
190 circulatory disorders with acute myocardial
infarction
192 cardiac catheterization for ischemic heart
disease
196 cardiac arrest, unexplained
202 angina Pectoris
Online Table 2
coronary artery disease and related conditions
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unit of the Department of neurology of the univer-
sity hospitals leuven in the year 2006-2007 with the
coding of cases provided by the government data-
base for the same years. The leuven database
prospectively registers all admissions for suspected
ischemic stroke and Tia to the stroke unit. sub-
arachnoid hemorrhages are not recorded in this data-
base, nor are endarterectomy procedures for
asymptomatic carotid stenosis. a final diagnosis is
recorded by a neurologist specialized in cerebro -
vascular disorders based on clinical and imaging
data. Patients are divided into a discharge diagnosis
of ischemic stroke, any cerebral hemorrhage,
 transient ischemic attack and non-stroke. we also
 register whether carotid endarterectomy is
 performed during the admission. Patients with
 dissections without cerebral ischemia and patients
with cerebral venous thrombosis are coded as non-
stroke. 
Second validation cohort
as the stroke registry is tailored towards ischemic
problems, we retrospectively studied an additional
sample of patients suffering from intracranial
 hemorrhage. The patients were recruited from the
stroke unit of the university hospitals leuven under
supervision of the treating neurosurgeon with admis-
sion diagnoses of intracerebral hemorrhage, sub-
arachnoid hemorrhage and subdural hematomas
between september 1th 2006 and august 31th 2007.
intracerebral hemorrhages and subarachnoid hemor-
rhages were classified as intracranial hemorrhages
by a stroke neurologist blinded to the results of the
aPR-DRG assignment. subdural hematomas were
not classified as intracranial hemorrhage. 
Statistics
For the administrative data analyses only group
level data and averages were used as no individual
data were available. spearman rank correlation
analysis was used to correlate demographic data,
length of stay and costs over time. For the validation
study, we measured the sensitivity and specificity
and 95% confidence intervals of the aPR-DRG
codes as compared to the discharge diagnosis. in the
first validation cohort, we compared first all stroke
related aPR-DRGs with any discharge diagnosis of
Tia, ischemic stroke, intracerebral hemorrhage or
the performance of a carotid endarterectomy.
 secondly, we compared the individual aPR-DRGs
with the discharge diagnosis or the performance of
carotid endarterectomy. in the second validation
 cohort we compared the discharge aPR-DRG with
discharge diagnosis. statistics were performed in
sPss 16.0. a two tailed p-value of smaller than 0.05
was considered significant.
Results
ValiDaTiOn sTuDY
First validation study
we enrolled 676 patients during the years 2006
and 2007 in the stroke registry. The discharge
 diagnosis was ischemic stroke in 476 (70%), Tia in
168 (25%) and intracerebral hemorrhage in 4 (1%).
a non-stroke diagnosis was made in 28 (4%)
 patients. carotid endarterectomy was performed in
33 (5%) patients with cerebral ischemia. The
 sensitivity of all stroke related aPR-DRG versus the
discharge diagnosis of any of ischemic stroke, in-
tracerebral hemorrhage or carotid endarterectomy
was 0.89 (95% ci, 0.88-0.90) and the specificity was
1 (95% ci, 0.88-1.00). For the individual diagnoses,
the sensitivity and specificity were as follows: for
the aPR DRG 45-46 versus discharge diagnosis
 ischemic stroke the sensitivity was 0.81 (95% ci
0.78-0.82) and the specificity 0.81 (95% ci 0.76-
0.85), for the aPR-DRG 47 versus Tia the sensitiv-
ity was 0.66 (95% ci 0.62-0.68) and the specificity
0.98 (95% ci 0.97-0.99), for the aPR-DRG 24
 versus carotid endarterectomy the sensitivity was
0.97 (95% ci 0.89-0.99) and the specificity 0.99
(95% ci 0.99-1.00). The main reason for differences
in aPR-DRG assignments and discharge diagnoses
was the (rightful) use of surgical codes for patients
with Tia or ischemic stroke because of performance
of surgical procedures during admission. 
Second validation study: Intracerebral hemorrhage
we enrolled 84 patients from the Department of
neurosurgery during the study period. The discharge
diagnosis was intracerebral hemorrhage in 51 (61%)
patients, subarachnoid hemorrhage in 26 (31%) and
other diagnoses in 7 (8%) patients. The sensitivity
of the aPR-DRG 44 versus any ich or sah was
0.46 (95% ci 0.42-0.47) and the specificity was 0.71
(95% ci 0.37-0.92). again, the main reason for the
differences between discharge diagnosis and aPR-
DRG assignments was the rightful use of surgical
codes in the aPR-DRG system because of perform-
ance of surgical procedures during admission.
analYsis OF aDminisTRaTiVe DaTaBase
Demographics 2002-2007
There were 32970 admissions for aPR-DRG
stroke related conditions in 2007. This represents
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2.0% of the total of 1569827 number of admissions
in Belgium. There were 3055(9.3%) admissions for
ich related aPR-DRG, 16239(49.3%) for ischemic
stroke related aPR-DRG and 7606(23.1%) for Tia
related aPR-DRG. additionally, cea related aPR-
DRG were coded during 4063 (12.3%) admissions. 
in 2007 the average age for patients admitted with
ich was 73 years, for ischemic strokes and Tia 75
years. Patients with cea were on average 71 years.
The age of patients with ich increased from 71 to
73 years between 2002 and 2007 (ρ = 0.926, p =
0.008) and remained stable for Tia and stroke.
Table 1 shows the number of stroke related con-
ditions during the years 2002-2007. in these 6 years
there was a significant decline of the numbers of
hospitalized patients by 4.6 percent (ρ = -0.943, p =
0.005). There was an important reduction in the use
of code DRG 46 and an increase in the use of code
DRG 45. combining these two, there was a net re-
duction of 5.4% (ρ = -1, p =  0.003). There was a
non-significant decrease of hospitalizations for Tia
with 7.4% (ρ = -0.77, p = 0.072). The frequency of
admissions for carotid endarterectomy and ich did
not change over time. 
Length of stay
in 2007 the average length of stay for ich related
aPR-DRG was 17 days, for strokes with brain in-
farction 20 days, for ill defined strokes 12 days and
for Tia 9 days. Patients who underwent extracranial
vascular interventions stayed on average 8 days. The
average length of stay for all patients with stroke and
related disorders was 14 days. except for a decline
in the length of stay for aPR-DRG 46 (ρ = -0.986,
p = 0.001) and a minor decline in the length of stay
for Tia (ρ = -0.845,p = 0.03) and cea (ρ = -0.926,
p = 0.008), there is no clear reduction over time (data
not shown). 
Costs of hospitalization
Table 2 provides cost data for the period 2002 and
2007. The total cost for stroke and related diseases
admissions was 191.62 million euRO in 2007. This
represents 2.9% of the total budget of hospital ad-
missions in Belgium and 0.69% of the total health
care expenditures by RiZiV/inami in Belgium for
2007 (12). The average cost per patient was
6189 euRO, varying between 3859 euRO for
 patients with Tia up to 7792 euRO for patients with
stroke and brain infarction. There was no reduction
of costs over time (ρ = 0.429, p = 0.4). There was no
correlation between the number of admissions and
costs (ρ = -0.143, p = 0.79). There also was no clear
correlation between length of stay and costs (data
not shown). 
Comparison with hospitalization for coronary artery
disease (CAD)
There were 68867 admissions for caD related
disorders in 2007. This represents 4.4% of all
 Belgian admissions for that year. The average cost
per admission was 5026 €. The total cost was
351.98 million €. This represents 5.3% of the total
budget for hospital admissions and 1.3% of the
health care expenditures of RiZiV/inami (2007). 
Discussion
There is a need for real time monitoring of the
prevalence and incidence of common diseases, like
stroke or ischemic heart disease in order to target
Year 2007 2006 2005 2004 2003 2002
DRG 44 intracranial hemorrhage 3055 3106 3023 3116 2910 3047
DRG 45 stroke with brain infarction 14159 13866 13035 10357 8977 7648
DRG 46 ill-defined stroke 2080 2722 3652 6331 8177 9514
All stroke 19294 19694 19710 19804 20064 20209
DRG 47 Tia 7606 7558 7545 7823 7982 8214
DRG 24 interventions on extracranial vessels 4063 4223 4185 4287 3902 4045
Total numbers of stroke related admissions, n 32970 33481 33445 33918 33951 34470
Total numbers of admissions ,n 1569827 1594501 1557245 1526872 1532567 1525454
Stroke related admission as % of total number of 
admissions
2.0 2.1 2.1 2.2 2.2 2.3
Table 1
number of admissions per year
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health care resources appropriately and to assess the
effect of health interventions on a population basis.
large scale, population based studies are the ideal
source to study the epidemiology of these diseases
but these studies are difficult to perform and are
 expensive. in order to provide the necessary num-
bers of endpoints to provide reliable estimates they
require the follow up of a large population of sub-
jects over a long period. Data from large government
databases or insurance companies could provide a
faster way to study trends in incidence over time pro-
vided they are accurate. in Belgium there is a dearth
of  epidemiologic studies. however, every year ad-
ministrative data regarding hospitalizations are made
publicly available. These administrative data provide
nationwide information on the aPR-DRG codes and
on their associated costs. we sought first to correlate
these administrative categorizations intended for re-
imbursement purposes with actual discharge diag-
noses. we conclude from our study that the
aPR-DRG codes for ischemic stroke and Tia cor-
relate quite well with the discharge diagnosis. in
contrast, the aPR-DRG code for intracerebral
 hemorrhage severely underestimates the number of
admissions for ich and, by definition, includes a
non-stroke related condition (non-traumatic subdural
hematoma). using these administrative data, we
moreover show a reduction in the number of stroke
and related admissions over a period of 6 years. This
reduction in admissions is not paralleled by a reduc-
tion in hospitalization costs. Finally, we demonstrate
that the average cost per hospitalization for a stroke
related condition is higher than the cost for coronary
artery disease related diseases. Both stroke and coro-
nary artery disease pose an important burden on the
health care budget allocated to hospitalizations with
both conditions accounting together for 6.8% of the
entire hospitalization budget. 
Our study shows that ischemic stroke not only is
the most frequent neurovascular condition but also
suggests that it is the most expensive of these disor-
ders. we have to be cautious however to make this
conclusion as brain hemorrhage might be much
more expensive but this is not captured by the ad-
ministrative data due to important coding limitations
in ich aPR-DRGs as mentioned above. using
icD9 codes might be a more accurate way of deter-
mining the incidence of hospitalized ich (13). 
The sensitivity and specificity we found using
aPR-DRG codes for ischemic stroke is similar to the
accuracy of icD9 coding (14, 15). One study found
that when icD-9 codes were used the top five
 discharge diagnoses had to be taken into account to
accurately identify ischemic stroke (16).
The decrease in stroke hospitalization over time
we found is puzzling. The only published study on
the epidemiology of stroke in Belgium estimated an
annual incidence of hospitalized ischemic stroke of
11700 per year in the years 1998-1999 (7). accord-
ing to our study however, the rate of hospitalization
in 2007 had risen to about 16000 ischemic strokes.
compared to the epidemiological study, this is an in-
crease in hospitalization rate with 4300 patients or
37%. This does not of course necessarily mean an
increase in the actual number of ischemic strokes,
but probably indicates a higher admission rate given
Average cost (€) 2007 2006 2005 2004 2003 2002
DRG 44-ICB 6964 6863 5835 6000 6521 6045
DRG 45-CVA w/ brain infarction 7792 7768 6625 6654 7197 7135
DRG 46-Ill-defined stroke 4828 4854 4452 5238 5733 5701
DRG 47-TIA 3859 3753 3593 3615 3872 3781
DRG 24-CEA 5075 5148 4890 4782 5065 5008
average cost (€) 6189 6111 5338 5312 5670 5499
Total cost (million €) 2007 2006 2005 2004 2003 2002
DRG 44-ICB 21.27 21,32 17,64 18,70 18,98 18,42
DRG 45-CVA w/ brain infarction 110.33 107,71 86,36 68,92 64,61 54,57
DRG 46-Ill-defined stroke 10.04 13,21 16,26 33,16 46,88 54,24
DRG 47-TIA 29,35 28,37 27,11 28,28 30,91 31,06
DRG 24-CEA 20,62 21,74 20,46 20,50 19,76 20,26
Total cost (million €) 191.62 192,34 167,82 169,55 181,13 178,54
Table 2
average and total costs for stroke in the years 2002 to 2007
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the advent of new treatments and rising stroke
awareness and information campaigns urging rapid
admission for stroke (17). The hypothesis of easier
admission of ischemic strokes to hospital is however
at odds with the finding of a steady decrease in hos-
pitalization rates from 2002 onwards according to
our study. we suspect that different capture methods
used in the different studies might explain the differ-
ences in stroke rates between the GP study and the
hospital based administrative data. a decline of
stroke incidence has been noted in several epidemi-
ological studies in high income countries over the
past decades with the increased adoption of cardio-
vascular prevention measures (18-21). This decline
might have come to a standstill recently (22). 
Despite the decline in hospitalization rate we
could not demonstrate a proportionate reduction in
the global costs of caring for hospitalized stroke
 patients. This might be due to the adoption of a less
nihilistic attitude towards stroke over time with a
more thorough approach to diagnosis, more exten-
sive use of medical and paramedical resources and
more aggressive use of medication. however, these
more assertive attitudes would not be expected to
lead to the haphazard increase and decrease of global
costs we observed within a few years with variations
in costs of up to 14% (eg between 2005 and 2006).
These erratic cost fluctuations are difficult to inter-
pret without more detailed access to the causes of
the cost variations. 
it is often thought that the hospitalization of
 patients with cardiac disorders is very expensive
given the extensive use of advanced diagnostic tech-
nology and the access to costly therapeutic proce-
dures like coronary artery stenting and coronary
bypass grafting. although it is true there are very
costly aPR-DRGs for some cardiac disorders, the
average cost is 13% lower than the cost of stroke.
One obvious difference explaining the high cost is
the approximate threefold length of stay difference
between stroke and mi. correcting for length of stay
leads to a higher per diem cost for coronary artery
disease of about 1000 euRO compared to
400 euRO for stroke. 
Our study has limitations. Data from administra-
tive registries suffer from limitations (16, 23). The
costs we calculated have not been validated by a
 bottom up approach and some costs might not have
been taken into account. The big advantage of
 administrative data is their face validity especially
from the viewpoint of the government and insurance
companies. Our comparison between discharge
 diagnosis and aPR-DRG assignment was performed
in only one academic center. This should be ex-
tended to more academic and non-academic centers.
The stroke registry we used does not capture stroke
patients hospitalized outside of a stroke unit and may
be therefore biased. also, we did not correlate the
codes from coronary artery diseases with discharge
diagnoses. also, in a minority of patients myocardial
ischemia and stroke may have coexisted, yet in those
cases a single aPR-DRG is assigned. Our data are
also already a few years old because of the publica-
tion delay of the administrative data on the website. 
we conclude that the global cost of hospitalization
for stroke and related disorders is high. although
coronary artery disease is more frequent and has a
larger impact on the health care expenditures, the av-
erage cost per hospitalization is higher for stroke and
related diseases. This finding is mainly due to the
longer hospitalization duration for stroke. hospital-
ization administrative data can be used to monitor
the incidence of hospitalized ischemic stroke but not
for intracranial hemorrhage. 
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